Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.55 |
| ▸ | DRD3 | P35462 | 4/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | LPL | P06858 | 2/20 | 0.51 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | DRD1 | P21728 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | DRD5 | P21918 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29974231 | 1.00 | DRD2 (0.55) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL135991 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL1838969 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL3358472 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL649958 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL1838540 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL530294 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL1835798 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL6558135 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 | |
| SCHEMBL7918878 | 0.89 | PTGS2 (0.66) | DRD2DRD3OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577215-B2 | Triazine UV absorbers and a process for the preparation thereof | BASF SE (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20230088507-A1 | TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF | BASF SE (DE) | 2023-03-23 | — | — | US | disclosed |
| EP-4081510-A1 | TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF | BASF SE (DE) | 2022-11-02 | — | — | EP | disclosed |
| CN-114901645-A | Triazine UV absorbent and preparation method thereof | 巴斯夫欧洲公司 | 2022-08-12 | — | — | CN | disclosed |
| WO-2021130380-A1 | TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF | BASF SE (DE) | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577215-B2 | Triazine UV absorbers and a process for the preparation thereof | CYP2R1, NR2E3, SRD5A2 | DRD2 681/4885DRD3 647/4885OPRM1 247/4885 |
| US-20230088507-A1 | TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF | NISCH, DHPS, UMPS | DRD2 2801/4885DRD3 3041/4885OPRM1 4154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.